No abstract available
Keywords:
Mycobacterium avium complex; Hodgkin disease; brentuximab vedotin; immunoconjugates.
MeSH terms
-
Adolescent
-
Animals
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Brentuximab Vedotin / adverse effects*
-
Brentuximab Vedotin / therapeutic use
-
CD30 Ligand / genetics
-
CD30 Ligand / metabolism
-
Disease Models, Animal
-
Drug Therapy
-
Female
-
Hodgkin Disease / complications*
-
Hodgkin Disease / diagnostic imaging
-
Hodgkin Disease / drug therapy
-
Hodgkin Disease / pathology
-
Humans
-
Immunoconjugates / adverse effects
-
Immunoconjugates / immunology
-
Lung / pathology
-
Mice
-
Mycobacterium avium Complex / pathogenicity*
-
Mycobacterium avium-intracellulare Infection / complications*
-
Mycobacterium avium-intracellulare Infection / microbiology
-
Mycobacterium avium-intracellulare Infection / pathology
Substances
-
Antineoplastic Agents
-
CD30 Ligand
-
Immunoconjugates
-
TNFSF8 protein, human
-
Brentuximab Vedotin